Skip to content

Samuel Maddams

3 papers in the library · 12 citations · publishing 2025-2026

Papers

Sort Most recent Most cited

Views on Psychedelic-Assisted Therapy for Substance Use Disorders from Individuals with Opioid Use Disorder and a History of Injection-Related Infections: A Qualitative Study.

Psychedelic medicine (New Rochelle, N.Y.) March 1, 2026 Veronica Szpak, Samuel Maddams, Amanda Kim et al.

New treatment options are needed to improve outcomes for patients with both opioid use disorder (OUD) and injection-related infections. Psychedelic-assisted therapy (PAT) has been suggested as a potential treatment for substance use disorders (SUD). To address this need, a qualitative study was conducted to understand the attitudes toward PAT from individuals with OUD who have survived...

Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.

Journal of Addiction Medicine May 28, 2025 Sara Prostko, Alexander Wu, Samuel Maddams et al. 2 citations

Psychedelics may be promising treatments for substance use disorders (SUD). This study aims to understand how individuals with alcohol use disorder (AUD), opioid use disorder (OUD), and psychiatric disorders perceive and experience psychedelics for both nonmedical and medical use. Data for this cross-sectional survey study were collected from June 2023 to February 2024 at a large, tertiary...

Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review.

Frontiers in Psychiatry 2025 Mary R Shen, Dylan E Campbell, Anika Kopczynski et al. 10 citations

Opioid use disorder (OUD) continues to be a public health crisis in the United States, with mortality having doubled over the last twenty years, leading to significant economic cost, morbidity, and mortality. This has caused significant demand for novel therapeutics. Preliminary evidence demonstrates that ketamine may be helpful in treating OUD as well as serve as an adjunct during treatment of...